Part 3: Clinical Trials and COVID-19 Adapting to Rapid Change
April 28, 2020
TransPerfect's Trial Interactive hosted Part 3 of the Clinical Trials and COVID-19 webinar series with representatives from a Sponsor and Site to discuss how they are helping their team members navigate this new landscape.
Part 2: Clinical Trials and COVID-19: Converting to Remote Trial Management – How to Get Started
April 23, 2020
TransPerfect’s Trial Interactive will be hosting a webinar with the CEO of MANA RBM for organizations considering making the transition from largely manual, paper-based processes to complete remote trial management.
Part 1: Clinical Trials and COVID-19: Situation Now, Its Challenges, and the Future
April 14, 2020 | 11:00 AM ET
TransPerfect Life Sciences will be hosting an interactive session with industry experts from Ferring Pharmaceuticals, Merck, and Clinical Innovation Partners (ex Pfizer).
Simplifying Clinical Trial Training Management
December 20, 2019
Marc Gracieux, GlobalLearn Product Manager
Lay Summary Development Navigating the Trail of Regulatory Writing
October 22, 2019
Kelsey Brown, Medical Writing Manager, TransPerfect
The Right eTMF Approach for You: Sponsor or CRO-Owned eTMF?
June 18, 2019
Laurel-Ann Schrader – Associate Director, Clinical Operations, TransPerfect Trial Interactive
Mof Osei – Senior Director, Records Management Compliance, Worldwide Clinical Trials
Le Thu Nguyen – Senior Clinical Documentation Manager, Sponsor
Rethinking Medical Device go-to-market clinical strategies in the light of the new European MDR
May 2, 2019
Meghan McCrea – Regional Director, TransPerfect Life Sciences
Adam Steadman – VP Clinical Development, Business Unit Head, Medical Devices & Diagnostics at Syneos
Content Requirements Under MDR…And What You Can Do About It
June 27, 2019
Marc Miller - Division President, TransPerfect Medical Device Solutions
Keith Morel, PhD – VP of Regulatory Compliance / Principal Consultant Qserve Group


-- close --